Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COVID-19
Biotech
Moderna won't advance US-backed Zika vaccine without more money
Moderna will not advance a midstage Zika vaccine without more cash, despite receiving U.S. funding, according to a regulatory disclosure.
Max Bayer
Mar 15, 2024 11:10am
Protease inhibitor outperforms Paxlovid protecting lungs of mice
Mar 14, 2024 6:30am
Layoffs at Meissa Vaccines as biotech's future lies in limbo
Mar 5, 2024 10:25am
Gritstone lays off 40% of team after delaying COVID vax trial
Feb 29, 2024 4:05pm
CytoDyn finally clears FDA hold on HIV program after 2 years
Feb 29, 2024 10:20am
Investors home in on Moderna's RSV, CMV prospects
Feb 22, 2024 10:09am
More News
NIH to invest another $515M over 4 years for long COVID research
Feb 15, 2024 10:57am
Veru needs cash for fresh trial of respiratory distress drug
Feb 8, 2024 10:45am
Revvity revenue drops 17% in first year after spinout
Feb 1, 2024 10:52am
Novavax's 2nd round of job cuts impacted 12% of staff
Jan 31, 2024 11:57am
See more stories